Evolution-proof inhibitors of public good cooperation: a screening strategy inspired by social evolution theory.

Lissens, Maries; Joos, Mathieu; Lories, Bram; Steenackers, Hans P

Lissens, Maries; Joos, Mathieu; Lories, Bram; Steenackers, Hans P.

Afiliación

Lissens M; Centre of Microbial and Plant Genetics (CMPG), Department of Microbial and Molecular Systems, KU Leuven, Leuven, B-3001, Belgium.
Joos M; Centre of Microbial and Plant Genetics (CMPG), Department of Microbial and Molecular Systems, KU Leuven, Leuven, B-3001, Belgium.
Lories B; Centre of Microbial and Plant Genetics (CMPG), Department of Microbial and Molecular Systems, KU Leuven, Leuven, B-3001, Belgium.
Steenackers HP; Centre of Microbial and Plant Genetics (CMPG), Department of Microbial and Molecular Systems, KU Leuven, Leuven, B-3001, Belgium.

FEMS Microbiol Rev ; 46(5)2022 10 28.

Article en En | MEDLINE | ID: mdl-35675280

Asunto(s)

Evolución Biológica; Evolución Social; Investigación

Palabras clave

Anti-virulence drugs; Antimicrobial resistance; Drug screening/target identification; Evolutionarily-robust drugs; Interference with public good cooperation; Microbial social evolution

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Evolución Biológica / Evolución Social Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: FEMS Microbiol Rev Asunto de la revista: MICROBIOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Bélgica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google